☆ 4.2 Article

Cardiogenic shock etiology and exit strategy impact survival in patients with Impella 5.5

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients

Danny Ramzy et al.

Summary: A study shows that a redesigned heart pump implantation device has improved clinical characteristics and outcomes compared to the previous generation, especially for patients with acute myocardial infarction complicated by cardiogenic shock. The study also found that patients using the new device had higher survival rates and longer duration of support.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

添加到收藏夹

Article Medicine, General & Internal

Temporary Mechanical Circulatory Support in Patients with Cardiogenic Shock: Clinical Characteristics and Outcomes

Michael Abiragi et al.

Summary: Patients with cardiogenic shock may require temporary mechanical circulatory support (tMCS) to assess candidacy for definitive therapy or maintain stability. This study compares the outcomes of patients who received intra-aortic balloon pump (IABP) vs. Impella support at a high-volume advanced heart failure center. Despite the worse condition of patients who received Impella support, a high proportion of them were successfully stabilized. These findings highlight the heterogeneity of the cardiogenic shock patient population and may guide future trials on different tMCS devices.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Single center experience and early outcomes of Impella 5.5

Masaki Funamoto et al.

Summary: This study retrospectively analyzed 70 patients who underwent Impella 5.5 implantation and showed that Impella 5.5 provides favorable survival in the management of acute decompensated heart failure and cardiogenic shock, particularly used as a bridge to heart transplant or LVAD.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

添加到收藏夹

Article Engineering, Biomedical

Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy

Mohit Pahuja et al.

Summary: Trans-valvular micro-axial flow pumps like Impella, specifically the Impella 5.0 and 5.5 systems, are increasingly used in patients with cardiogenic shock due to their excellent safety and efficacy profiles. They provide circulatory support, myocardial unloading, and allow for axillary placement, enabling patient mobilization and rehabilitation.

EXPERT REVIEW OF MEDICAL DEVICES (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impella Support Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Meta-Analysis

Abdelmoniem Moustafa et al.

Summary: In patients with acute myocardial infarction complicated by cardiogenic shock (AMICS), the use of Impella device does not provide a survival advantage over intra-aortic balloon pump (IABP), but is associated with a higher risk of bleeding, limb complications, and hemolysis.

CARDIOVASCULAR REVASCULARIZATION MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Microaxial Left Ventricular Assist Device Versus Intraaortic Balloon Pump as a Bridge to Transplant

Taylor Nordan et al.

Summary: This study compared the effectiveness of Impella and IABP as bridges to heart transplantation and found no significant differences in post-transplant survival rates between the two groups. However, Impella-supported candidates had worse preoperative profiles and were more likely to be delisted from the waitlist under the new allocation system.

ANNALS OF THORACIC SURGERY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Incidence, predictors, and clinical outcomes of mechanical circulatory support-related complications in patients with cardiogenic shock

Kotaro Takahashi et al.

Summary: This study retrospectively explored predictors and clinical outcomes of device-related complications in patients with mechanical circulatory support. The results showed that major bleeding had the greatest impact, and the type of implanted MCS was associated with complications.

JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Single center first year experience and outcomes with Impella 5.5 left ventricular assist device

Joanna R. Rock et al.

Summary: This study retrospectively analyzed the use of Impella 5.5 (R) for mechanical circulatory support and found that it can achieve favorable patient outcomes beyond 14 days. The incidence of complications was comparable to other similar devices.

JOURNAL OF CARDIOTHORACIC SURGERY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes

Shashank S. Sinha et al.

Summary: Patients with HF-CS were younger and less likely to receive vasopressors or temporary mechanical circulatory support compared to AMI-CS patients, resulting in lower in-hospital and 1-year mortality rates.

CIRCULATION-HEART FAILURE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Criteria for Defining Stages of Cardiogenic Shock Severity

Navin K. Kapur et al.

Summary: This study aims to test parameters that define SCAI stages and explore their utility as predictors of in-hospital mortality in cardiogenic shock (CS) patients. The results indicate that lower baseline stage is associated with a higher incidence of stage escalation and a shorter duration of time to reach the maximum stage. This novel approach may improve the clinical application of the staging system and provide new insights into the trajectory of hospitalized CS patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

Mechanical Circulatory Support Devices for the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction-A Review

Sharon Bruoha et al.

Summary: Cardiogenic shock complicating acute myocardial infarction is a complex clinical condition with poor prognosis. Early target vessel revascularization is the most effective treatment, but mortality remains high. Temporary circulatory support devices aim to enhance cardiac unloading and improve organ perfusion, but there is a lack of quality evidence to guide device selection and management, highlighting the importance of multidisciplinary expert care.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Use of Impella device in cardiogenic shock and its clinical outcomes: A systematic review and meta-analysis

Giuseppe Panuccio et al.

Summary: This meta-analysis evaluated the clinical impact of Impella in patients with cardiogenic shock. The results suggest that the choice of adequate device size, careful patients selection and optimal timing of MCS initiation are key to clinical success with Impella in CS.

IJC HEART & VASCULATURE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time

Jacob C. Jentzer et al.

Summary: The prevalence of shock in the CICU has increased over time, with a significant prevalence of mixed cardiogenic-septic shock. The etiology of cardiogenic shock has changed over the last decade, with heart failure overtaking acute coronary syndrome as the most common cause of cardiogenic shock in the CICU.

AMERICAN HEART JOURNAL (2021)

添加到收藏夹

Article Surgery

Early Outcomes of the First 200 US Patients Treated with Impella 5.5: A Novel Temporary Left Ventricular Assist Device

Danny Ramzy et al.

Summary: The initial clinical experience with the Impella 5.5 showed an overall survival rate of 74%, with lower survival rates observed in patients requiring both extracorporeal membrane oxygenation and Impella support. Further prospective studies are needed to compare the performance of this device with conventional strategies in the future.

INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY (2021)

添加到收藏夹

Article Medicine, General & Internal

Adverse Events of Percutaneous Microaxial Left Ventricular Assist Devices-A Retrospective, Single-Centre Cohort Study

Anna S. Zaiser et al.

Summary: Impella (R) is increasingly used in patients with acute cardiogenic shock or undergoing high-risk cardiac interventions. Despite its long history of use, few studies have assessed its safety and possible complications. Common complications include bleeding, hemolysis, and acute kidney injury, highlighting the importance of careful patient selection and indication definition for LV support.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction

Mina Karami et al.

Summary: The study compared long-term outcomes and functional status of patients with cardiogenic shock treated with percutaneous mechanical circulatory support (pMCS) and intra-aortic balloon pump (IABP). There was no significant difference in 5-year mortality between the two treatment groups, but the occurrence of major adverse cardiac and cerebrovascular events (MACCE) differed. Most survivors had good heart function and no residual angina.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)

添加到收藏夹

Article Transplantation

Impact of New UNOS Allocation Criteria on Heart Transplant Practices and Outcomes

Jason Liu et al.

Summary: The implementation of a new heart allocation policy led to changes in bridging strategy at the institution, with increased usage of temporary mechanical support and decreased support with durable LVADs. However, there were no significant differences in early posttransplant outcomes.

TRANSPLANTATION DIRECT (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study

Michael P. Flaherty et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2020)

添加到收藏夹

Article Surgery

Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device

Laura Seese et al.

CLINICAL TRANSPLANTATION (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis

Benedikt Schrage et al.

CIRCULATION (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction

Dagmar M. Ouweneel et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Importance of stratifying acute kidney injury in cardiogenic shock resuscitated with mechanical circulatory support therapy

Andrew I. Abadeer et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical picture and risk prediction of short-term mortality in cardiogenic shock

Veli-Pekka Harjola et al.

EUROPEAN JOURNAL OF HEART FAILURE (2015)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Cardiac remodeling and physical training post myocardial infarction

Michael A. Garza et al.

WORLD JOURNAL OF CARDIOLOGY (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction

Melchior Seyfarth et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.